Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,729 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Ge Z, Kan J, Gao X, Raza A, Zhang JJ, Mohydin BS, Gao F, Shao Y, Wang Y, Zeng H, Li F, Khan HS, Mengal N, Cong H, Wang M, Chen L, Wei Y, Chen F, Stone GW, Chen SL; ULTIMATE-DAPT investigators. Ge Z, et al. Among authors: wei y. Lancet. 2024 May 11;403(10439):1866-1878. doi: 10.1016/S0140-6736(24)00473-2. Epub 2024 Apr 7. Lancet. 2024. PMID: 38599220 Clinical Trial.
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
Li X, Ge Z, Kan J, Anjum M, Xie P, Chen X, Khan HS, Guo X, Saghir T, Chen J, Gill BUA, Guo N, Sheiban I, Raza A, Wei Y, Chen F, Mintz GS, Zhang JJ, Stone GW, Chen SL; IVUS-ACS Investigators. Li X, et al. Among authors: wei y. Lancet. 2024 May 11;403(10439):1855-1865. doi: 10.1016/S0140-6736(24)00282-4. Epub 2024 Apr 8. Lancet. 2024. PMID: 38604212 Clinical Trial.
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial.
Kan J, Zhang H, Xie D, Wei Y, Zhang J, Zhang C, Yang Z, Gu H, Fan F, Gu H, Wang Q, Zhang G, Guo X, Yin Y, Wang X, Jin B, Zhou H, Yang Z, Wang Z, Xin Y, Zhang C, Meng L, Wang X, Zhao C, Yan X, Chen F, Yao C, Stone GW, Chen SL. Kan J, et al. Among authors: wei y. EuroIntervention. 2023 Oct 23;19(8):684-694. doi: 10.4244/EIJ-D-23-00349. EuroIntervention. 2023. PMID: 37458100 Free article.
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
Zhang J, Kan J, Wei Y, Zhang C, Yang Z, Gu H, Fan F, Gu H, Wang Q, Xie D, Zhang G, Guo X, Yin Y, Jin B, Zhou H, Yang Z, Wang Z, Xin Y, Zhang C, Meng L, Wang X, Zhao C, Zhang H, Yan X, Chen F, Yao C, Benza RL, Stone GW, Chen SL. Zhang J, et al. Among authors: wei y. J Heart Lung Transplant. 2023 Aug;42(8):1140-1151. doi: 10.1016/j.healun.2023.03.015. Epub 2023 Mar 28. J Heart Lung Transplant. 2023. PMID: 36990173 Clinical Trial.
22,729 results
You have reached the last available page of results. Please see the User Guide for more information.